Companies: 10,795·Total market cap: $144.5T
Monterey Bio Acquisition Corporation

Monterey Bio Acquisition Corporation

MTRYNASDAQFinancial Services
$11.14
$-0.03(-0.27%)
Market Cap$48302260
P/E Ratio
52W High$12.0
52W Low$10.21
Overview

Monterey Bio Acquisition Corporation (MTRY) · Income Statement

Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.

FMP · MTRY · as of 2026-06-09

Financial statements

Revenue · Gross Profit · Net Income
Breakdown2022-122021-122020-12
Revenue
Revenue$0.00B$0.00B$0.00B
Cost of Revenue$0.00B$0.00B$0.00B
Gross Profit($0.00B)$0.00B$0.00B
Gross Margin %(computed)
Operating Expenses
R&D Expenses$0.00B$0.00B$0.00B
G&A Expenses$0.00B$0.00B$0.00B
Total Operating Expenses$0.00B$0.00B$0.00B
Operating Income($0.00B)($0.00B)($0.00B)
Operating Margin %(computed)
Interest Income$0.00B$0.00B$0.00B
Interest Expense$0.00B$0.00B$0.00B
Income Before Tax($0.00B)($0.00B)($0.00B)
Income Tax Expense$0.00B($0.00B)$0.00B
Net Income($0.00B)($0.00B)($0.00B)
Net Margin %(computed)
Per Share & EBITDA
EPS (Basic)$-0.44$-0.04$-0.00
Wtd Avg Shares0.00B0.01B0.00B
EBITDA($0.00B)($0.00B)$0.00B
EBITDA Margin %(computed)

Data source: Financial Modeling Prep · Last updated: 2026-06-09 · USD · B

Explore more Monterey Bio Acquisition Corporation data

About Monterey Bio Acquisition Corporation (MTRY) Income Statement

Monterey Bio Acquisition Corporation (MTRY) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2022, MTRY reported revenue of $0.00B, gross profit of ($0.00B) (gross margin —), and net income of ($0.00B) — a net profit margin of —.

Frequently asked questions

MTRY · 4 questions

Monterey Bio Acquisition Corporation (MTRY) reported revenue of $0.00B for 2022, down —% year-over-year.

MTRY revenueMTRY salesannual revenue YoYincome statement

· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09